| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue | 3,088,256 | 2,799,528 | 2,615,101 | 2,887,400 | | Cost of Revenue | 2,856,480 | 2,608,561 | 2,466,512 | 2,731,854 | | | Gross Profit | 231,776 | 190,967 | 148,589 | 155,546 | | | Operating Expenses | | Research Development | 7,697 | 8,714 | 7,198 | 5,754 | | Selling General and Administrative | 131,553 | 127,807 | 125,419 | 111,053 | | Non Recurring | 3,435 | 3,582 | 16,167 | 736,645 | | Others | 7,105 | 7,719 | 7,612 | 7,673 | | | | Total Operating Expenses | 149,790 | 147,822 | 156,396 | 861,125 | | | | Operating Income or Loss | 66,264 | 43,145 | (7,807) | (705,579) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15,853) | (13,830) | 139 | 1,063 | | Earnings Before Interest And Taxes | 66,133 | 29,315 | (7,668) | (704,516) | | Interest Expense | 20,116 | 19,393 | 19,043 | 20,077 | | Income Before Tax | 46,017 | 9,922 | (26,711) | (724,593) | | Income Tax Expense | 17,136 | 3,989 | 2,528 | 142,018 | | Minority Interest | (593) | (426) | 477 | 511 | | | | Net Income From Continuing Ops | 28,288 | 5,507 | (28,762) | (866,100) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 28,288 | 5,507 | (28,762) | (866,100) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $28,288 | $5,507 | ($28,762) | ($866,100) |
|
1.52% Nasdaq 
Income Statement
